Pharmaceutical

ESC 2024: Beta blocker treatment paradigm shifts for myocardial infarction

New data provides more evidence on choosing the ideal approach for prescription of beta blockers for myocardial infarction.

Sep 4, 2024 - 04:00
ESC 2024: Beta blocker treatment paradigm shifts for myocardial infarction
New data provides more evidence on choosing the ideal approach for prescription of beta blockers for myocardial infarction.
Read the original article

Tags:

Previous Article

Syntekabio and Enamine partner for AI-based drug development

Next Article

UAE MoHAP and Novo Nordisk partner for obesity management

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA committee proposes overhaul of perioperative lung cancer trials 

FDA committee proposes overhaul of perioperative lung c...

Jul 28, 2024

Immunocore and BMS partner to investigate first-line treatment for melanoma

Immunocore and BMS partner to investigate first-line tr...

Feb 22, 2024

Opinion: Do celebrity vaccine endorsements like Travis Kelce’s actually change behavior?

Opinion: Do celebrity vaccine endorsements like Travis ...

Nov 3, 2023